BTCY — BIOTRICITY INC.

OTC · Health Care · Health Care Equipment & Supplies · CIK 1630113 ·
Last close
$0.13
Market Cap
$2.61M
52W High
$0.17
52W Low
$0.09
ADV30
20,746
Next earnings
2026-11-12
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It also offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 4,250,632 3,399,024 694,557 -324,182 6,446,488 149,789 39,408,954
Dec 2025 3,987,819 3,251,476 440,915 -717,067 5,686,495 256,357 38,208,764
Sep 2025 3,885,795 3,181,498 273,819 -690,913 6,322,772 308,460 37,984,860
Jun 2025 3,873,993 3,116,800 281,945 -671,977 6,037,319 391,292 36,835,946

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-718,955
Investing CF
$0
Financing CF
$557,736
CapEx
Dividends Paid
$-24,033
Buybacks
$0
EPS Diluted TTM
$-0.15
As of
2026-08-23

Balance + Analyst (yfinance extras)

Retained Earnings
$-142,570,243
Inventory
$1,341,295
Receivables
$4,365,400
ST Investments
EBIT TTM
$1,703,707
Pretax Income TTM
$-2,404,139
Interest Exp TTM
$4,107,846
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$16,401,202
EBITDA
$1,573,312
Free Cash Flow
$2,008,246
Enterprise Value
$33,809,024
Total Cash
$1,773,304
Total Debt
$26,929,796
Shares Out
20,074,675
Trailing EPS
$-0.11
Book Value
$-1.21
ROE
ROA
16.2%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Mar 2026 15,998,239 1,691,236 -2,404,139 6,446,488 39,408,954 -718,955
Mar 2025 13,790,294 -2,448,966 -8,421,179 5,640,954 35,655,054 -2,380,177
Mar 2024 12,063,345 -8,828,269 -14,094,283 5,942,625 35,919,442 -6,693,912
Mar 2023 9,639,057 -15,409,711 -18,658,143 6,510,544 26,355,929 -13,547,935
Mar 2022

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.43

Peers — same industry

TickerNameMarket CapLastDaily %
SONX Sonendo, Inc. $2.62M $0.55
IVF INVO Fertility, Inc. $2.58M $1.03
ITOC iTonic Holdings Ltd $2.53M $0.27
ADMT ADM TRONICS UNLIMITED, INC. $2.70M $0.04
CUPR Cuprina Holdings (Cayman) LTD $2.51M $2.73

News headlines (Yahoo Finance, 1h cache)

Biotricity, Inc to Present at the LD Micro Invitational XVI
2026-05-12 12:15 · Yahoo
Q2 Investor Summit Virtual Live Wednesday June 24
2026-06-23 19:40 · Yahoo
Biotricity Inc (BTCY) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...
2026-02-12 05:02 · Yahoo
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
2026-02-11 21:00 · Yahoo
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th
2026-02-05 21:15 · Yahoo
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health
2025-12-24 14:58 · Yahoo
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run
2025-12-23 19:08 · Yahoo
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026
2025-11-14 21:00 · Yahoo
Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates
2025-11-13 14:40 · Yahoo
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates
2025-11-12 22:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.